Consistent with this, previous studies have identified that WTAP can function as both an oncogene and tumour suppressor dependent on cancer type (Bansal et al., 2014; Chen and Wang, 2018; Wu et al., 2019) and it may be that WTAP functions differently in varying stages of PCa. This evidence concerns the gene WTAP and posterior cortical atrophy.